Laurion Capital Management LP Castle Biosciences Inc Transaction History

Laurion Capital Management LP

  • $8.4 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$58.92 - $97.33 $294,600 - $486,650
-5,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$43.6 - $73.05 $218,000 - $365,250
5,000 New
5,000 $336,000
Q4 2019

Feb 13, 2020
SELL
$15.74 - $35.04 $471,979 - $1.05 Million
-29,986 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$18.09 - $27.92 $542,446 - $837,209
29,986 New
29,986 $542,000

Others Institutions Holding CSTL

# of Institutions
171
Shares Held
25.5M
Call Options Held
511K
Put Options Held
130K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $750M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email